EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models
Abhilash Venugopalan(National Cancer Institute), Udayan Guha(Center for Cancer Research)
Cited by 50
Related Papers
NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease
|Journal of Biological Chemistry|2023|71
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response
|Molecular Case Studies|2016|24
Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V
|bioRxiv (Cold Spring Harbor Laboratory)|2018|2